Brief: Little Green Pharma Says LGP Denmark Signs Three-Year Sales Agreement With Distribution Partner Demecan
19/04/2022 02:39
April 19 (Reuters) - Little Green Pharma:
* LGP DENMARK SIGNS THREE-YEAR SALES AGREEMENT WITH
DISTRIBUTION
PARTNER DEMECAN
* DEAL FOR SUPPLY OF CANNABIS FLOWER MEDICINES
* AGREEMENT REPRESENTS ANNUAL REVENUE OPPORTUNITY OF
APPROXIMATELY
A$9 MILLION
Source text for Eikon: ID:nASX7CYwV3
Further company coverage: LGP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Little Green Pharma
See all newsBrief: Little Green Pharma Says Cannatrek In Further Discussions With TGA In Relation To Investigation
Brief: Little Green Pharma Reports Qtrly Revenue Of A$12.5 Million
Brief: Little Green Pharma Announces Updated Second Court Date
Brief: Little Green Pharma Provides Scheme Update
Brief: Little Green Pharma Announces Termination Of Proposed Sale And Leaseback Transaction